Clinical Trials Directory

Trials / Completed

CompletedNCT04433936

Corneal Tomographic Parameters in TGD

Corneal Tomographic Analysis Among Patients With Thyroid Gland Dysfunction.

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ameera Gamal Abdelhameed · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The current study involved analysis of the corneal tomographic parameters of patients with thyroid gland dysfunction (hyperthyroidism or hypothyroidism), including those with an autoimmune etiology, in comparison to healthy controls without TGD, using pentacam, in an attempt to detect possible early corneal changes and to highlight whether early screening of those patients would be necessary for early detection of KC.

Detailed description

A total of 100 eyes of 50 patients with TGD and 100 eyes of 50 healthy controls were enrolled. Diagnosis of TGD was based on history, clinical examination and laboratory investigations. Exclusion criteria included previous thyroid medications, thyroidectomy, previous ocular surgery, corneal pathology and other risk factors of keratoconus (KC). All eyes were examined by Pentacam, (Oculus Optikgerate GmbH, Wetzlar, Germany). Pentacam parameters were compared between TGD patients and controls. Spearman's correlation coefficient between different pentacam parameters and the level of free T4 and TSH was calculated.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPentacam tomographyThe Pentacam maps were analyzed. The following anterior and posterior corneal surface parameters were evaluated by the Scheimpflug system: Kf, Ks, Kmax. The pachymetric map was analyzed, including CCT at the apex of the geometric center and CTmin. PPIavg, PPI min and PPI max were calculated . The Ambrósio relational thickness (ART) was calculated The posterior corneal elevation maps were evaluated and the posterior corneal elevation values relative to this reference were recorded. The back difference elevation and multimetric D index values were extrapolated from the difference map of the Belin/Ambrósio-enhanced ectasia display of the Pentacam system.

Timeline

Start date
2018-02-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2020-06-16
Last updated
2020-06-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04433936. Inclusion in this directory is not an endorsement.